ARK Genomic Revolution ETF
ARKG
ARKG
294 hedge funds and large institutions have $653M invested in ARK Genomic Revolution ETF in 2023 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 79 increasing their positions, 95 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
37% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 46
47% less call options, than puts
Call options by funds: $51.8M | Put options by funds: $97.2M
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
294
Holding in Top 10
–
Calls
$51.8M
Puts
$97.2M
Top Buyers
| 1 | +$38.5M | |
| 2 | +$32.9M | |
| 3 | +$27.7M | |
| 4 |
Morgan Stanley
New York
|
+$16.9M |
| 5 |
Goldman Sachs
New York
|
+$7.18M |
Top Sellers
| 1 | -$227M | |
| 2 | -$3.45M | |
| 3 | -$3.16M | |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$2.6M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.46M |